Anixa Biosciences Inc
(ANIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 10-2024 | 10-2023 | 10-2022 | 10-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,028 | -12,698 | -9,930 | -13,771 | -13,128 |
| Depreciation Amortization | -107 | 37 | 46 | 42 | 60 |
| Accounts receivable | 173 | 97 | -224 | -29 | N/A |
| Other Working Capital | 152 | 526 | -1,060 | 485 | 78 |
| Other Operating Activity | 3,637 | 4,703 | 4,959 | 6,781 | 8,052 |
| Operating Cash Flow | $-7,173 | $-7,335 | $-6,209 | $-6,492 | $-4,938 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,866 | 4,276 | -5,602 | -10,728 | -3,959 |
| PPE Investments | N/A | N/A | N/A | N/A | 35 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 7 |
| Investing Cash Flow | $4,866 | $4,276 | $-5,602 | $-10,728 | $-3,917 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,280 | 3,421 | 366 | 452 | 31,566 |
| Common Stock Repurchased | N/A | -6 | N/A | N/A | N/A |
| Financing Cash Flow | $2,280 | $3,415 | $366 | $452 | $31,566 |
| Beginning Cash Position | 1,271 | 915 | 12,360 | 29,128 | 6,417 |
| End Cash Position | 1,244 | 1,271 | 915 | 12,360 | 29,128 |
| Net Cash Flow | $-27 | $356 | $-11,445 | $-16,768 | $22,711 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,173 | -7,335 | -6,209 | -6,492 | -4,938 |
| Free Cash Flow | -7,173 | -7,335 | -6,209 | -6,492 | -4,938 |